Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Breast Cancer Screening: Assessment of Its Feasibility and Acceptability in the National Health System

NCT03791008 is registered in ClinicalTrials.gov with Institut de Recerca Biomèdica de Lleida as lead sponsor.

NCT NCT03791008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03791008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Breast Cancer Screening: Assessment of Its Feasibility and Acceptability in the National Health System
Lead sponsor
Institut de Recerca Biomèdica de Lleida
Phase
Not applicable
Overall status
Completed
Start date
January 30, 2019
Completion date
December 31, 2021
Enrollment
387 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer